| Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma LE Abrey, TT Batchelor, AJM Ferreri, M Gospodarowicz, EJ Pulczynski, ... Journal of clinical oncology 23 (22), 5034-5043, 2005 | 959 | 2005 |
| Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience AJM Ferreri, JY Blay, M Reni, F Pasini, M Spina, A Ambrosetti, ... Journal of Clinical Oncology 21 (2), 266-272, 2003 | 952 | 2003 |
| MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression … S Hu, ZY Xu-Monette, A Tzankov, T Green, L Wu, A Balasubramanyam, ... Blood, The Journal of the American Society of Hematology 121 (20), 4021-4031, 2013 | 848 | 2013 |
| High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial AJM Ferreri, M Reni, M Foppoli, M Martelli, GA Pangalis, M Frezzato, ... The Lancet 374 (9700), 1512-1520, 2009 | 739 | 2009 |
| Evidence for an Association Between Chlamydia psittaci and Ocular Adnexal Lymphomas AJM Ferreri, M Guidoboni, M Ponzoni, C De Conciliis, S Dell’Oro, ... Journal of the National Cancer Institute 96 (8), 586-594, 2004 | 693 | 2004 |
| Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’1 AJM Ferreri, E Campo, JF Seymour, R Willemze, F Ilariucci, A Ambrosetti, ... British journal of haematology 127 (2), 173-183, 2004 | 660 | 2004 |
| Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue E Zucca, A Conconi, E Pedrinis, S Cortelazzo, T Motta, ... Blood, The Journal of the American Society of Hematology 101 (7), 2489-2495, 2003 | 645 | 2003 |
| Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group E Zucca, A Conconi, TI Mughal, AH Sarris, JF Seymour, U Vitolo, R Klasa, ... Journal of Clinical Oncology 21 (1), 20-27, 2003 | 592 | 2003 |
| Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the … AJM Ferreri, K Cwynarski, E Pulczynski, M Ponzoni, M Deckert, LS Politi, ... The Lancet Haematology 3 (5), e217-e227, 2016 | 587 | 2016 |
| Diffuse large B-cell lymphoma M Martelli, AJM Ferreri, C Agostinelli, A Di Rocco, M Pfreundschuh, ... Critical reviews in oncology/hematology 87 (2), 146-171, 2013 | 578 | 2013 |
| Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meeting M Ponzoni, AJM Ferreri, E Campo, F Facchetti, L Mazzucchelli, T Yoshino, ... Journal of clinical oncology 25 (21), 3168-3173, 2007 | 534 | 2007 |
| Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type A Conconi, G Martinelli, C Thiéblemont, AJM Ferreri, L Devizzi, ... Blood 102 (8), 2741-2745, 2003 | 490 | 2003 |
| A multicenter study of treatment of primary CNS lymphoma AJM Ferreri, M Reni, F Pasini, A Calderoni, U Tirelli, A Pivnik, GM Aondio, ... Neurology 58 (10), 1513-1520, 2002 | 449 | 2002 |
| Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial NH Fowler, M Dickinson, M Dreyling, J Martinez-Lopez, A Kolstad, ... Nature medicine 28 (2), 325-332, 2022 | 445 | 2022 |
| Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology K Hoang-Xuan, E Bessell, J Bromberg, AF Hottinger, M Preusser, R Rudà, ... The Lancet Oncology 16 (7), e322-e332, 2015 | 405 | 2015 |
| Primary cardiac lymphoma in immunocompetent patients: diagnostic and therapeutic management GL Ceresoli, AJM Ferreri, E Bucci, C Ripa, M Ponzoni, E Villa Cancer: Interdisciplinary International Journal of the American Cancer …, 1997 | 384 | 1997 |
| Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS … AJM Ferreri, K Cwynarski, E Pulczynski, CP Fox, E Schorb, P La Rosée, ... The Lancet Haematology 4 (11), e510-e523, 2017 | 342 | 2017 |
| Clinical Activity of Rituximab in Gastric Marginal Zone Non-Hodgkin's Lymphoma Resistant to or Not Eligible for Anti–Helicobacter Pylori Therapy G Martinelli, D Laszlo, AJM Ferreri, G Pruneri, M Ponzoni, A Conconi, ... Journal of Clinical Oncology 23 (9), 1979-1983, 2005 | 315 | 2005 |
| Primary intraocular lymphoma: an international primary central nervous system lymphoma collaborative group report SA Grimm, JS Pulido, K Jahnke, D Schiff, AJ Hall, TN Shenkier, T Siegal, ... Annals of oncology 18 (11), 1851-1855, 2007 | 300 | 2007 |
| CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL … S Hu, ZY Xu-Monette, A Balasubramanyam, GC Manyam, C Visco, ... Blood, The Journal of the American Society of Hematology 121 (14), 2715-2724, 2013 | 296 | 2013 |